Premium
Eltrombopag for resistant immune thrombocytopenia secondary to chronic lymphocytic leukaemia
Author(s) -
Jolliffe E.,
Romeril K.
Publication year - 2014
Publication title -
internal medicine journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.596
H-Index - 70
eISSN - 1445-5994
pISSN - 1444-0903
DOI - 10.1111/imj.12468
Subject(s) - eltrombopag , medicine , splenectomy , immune thrombocytopenia , chronic lymphocytic leukemia , immunology , immune system , agonist , platelet , receptor , leukemia , spleen
Autoimmune manifestations are a common occurrence with chronic lymphocytic leukaemia ( CLL ). We describe a case of CLL ‐associated immune thrombocytopenia ( ITP ) that had a loss of response to standard treatment for ITP . The thrombopoeitin receptor agonist, eltrombopag, was successfully used preoperatively to increase the platelet count to a safer level, in this instance to facilitate laparoscopic splenectomy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom